Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27507 | 187 | 38.2 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1512 | 6953 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENETIC RADIOTHERAPY | Author keyword | 6 | 100% | 2% | 4 |
2 | GENE RADIOTHERAPY | Author keyword | 5 | 60% | 3% | 6 |
3 | PEDIAT MICROBIOL IMMUNOL RADIOL | Address | 4 | 56% | 3% | 5 |
4 | TNFERADE | Author keyword | 3 | 57% | 2% | 4 |
5 | CARG ELEMENTS | Author keyword | 3 | 42% | 3% | 5 |
6 | EGR 1 PROMOTER | Author keyword | 3 | 42% | 3% | 5 |
7 | HSVTK GCV | Author keyword | 1 | 50% | 1% | 2 |
8 | PROTON MED GRP | Address | 1 | 50% | 1% | 2 |
9 | RADIATION INDUCIBLE GENE THERAPY | Author keyword | 1 | 100% | 1% | 2 |
10 | RADIATION INDUCIBLE PROMOTERS | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENETIC RADIOTHERAPY | 6 | 100% | 2% | 4 | Search GENETIC+RADIOTHERAPY | Search GENETIC+RADIOTHERAPY |
2 | GENE RADIOTHERAPY | 5 | 60% | 3% | 6 | Search GENE+RADIOTHERAPY | Search GENE+RADIOTHERAPY |
3 | TNFERADE | 3 | 57% | 2% | 4 | Search TNFERADE | Search TNFERADE |
4 | CARG ELEMENTS | 3 | 42% | 3% | 5 | Search CARG+ELEMENTS | Search CARG+ELEMENTS |
5 | EGR 1 PROMOTER | 3 | 42% | 3% | 5 | Search EGR+1+PROMOTER | Search EGR+1+PROMOTER |
6 | HSVTK GCV | 1 | 50% | 1% | 2 | Search HSVTK+GCV | Search HSVTK+GCV |
7 | RADIATION INDUCIBLE GENE THERAPY | 1 | 100% | 1% | 2 | Search RADIATION+INDUCIBLE+GENE+THERAPY | Search RADIATION+INDUCIBLE+GENE+THERAPY |
8 | RADIATION INDUCIBLE PROMOTERS | 1 | 100% | 1% | 2 | Search RADIATION+INDUCIBLE+PROMOTERS | Search RADIATION+INDUCIBLE+PROMOTERS |
9 | CARG ELEMENT | 1 | 30% | 2% | 3 | Search CARG+ELEMENT | Search CARG+ELEMENT |
10 | RADIATION INDUCIBLE PROMOTER | 1 | 40% | 1% | 2 | Search RADIATION+INDUCIBLE+PROMOTER | Search RADIATION+INDUCIBLE+PROMOTER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EGR 1 PROMOTER | 7 | 43% | 7% | 13 |
2 | HEAT SENSITIVE PROMOTER | 4 | 50% | 3% | 6 |
3 | ALPHA GENE THERAPY | 4 | 56% | 3% | 5 |
4 | ADENOVECTOR | 2 | 67% | 1% | 2 |
5 | EGR 1 GENE | 1 | 33% | 1% | 2 |
6 | FOS ENHANCER | 1 | 50% | 1% | 1 |
7 | TISSUE SPECIFIC PROMOTER | 1 | 50% | 1% | 1 |
8 | FIBRIN HYDROGEL | 0 | 33% | 1% | 1 |
9 | GENE RADIOTHERAPY | 0 | 33% | 1% | 1 |
10 | SENSITIVE PROMOTER | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ionizing radiation: a genetic switch for cancer therapy | 2006 | 21 | 27 | 63% |
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers | 2009 | 24 | 68 | 40% |
Radiation therapy - Activation of gene transcription and the development of genetic radiotherapy - Therapeutic strategies in oncology | 2003 | 40 | 31 | 45% |
Chemoinducible gene therapy | 2005 | 1 | 22 | 73% |
Radiation and hypoxia inducible gene therapy systems | 2004 | 17 | 33 | 42% |
Radiation to control transgene expression in tumors | 2007 | 8 | 88 | 28% |
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy | 2002 | 61 | 68 | 21% |
Gene transfer: the challenge of regulated gene expression | 2008 | 30 | 96 | 13% |
Radiogenetic therapy: On the interaction of viral therapy and ionizing radiation for improving local control of tumors | 1997 | 13 | 20 | 40% |
Targeted gene therapy in radiotherapy | 2008 | 3 | 120 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PEDIAT MICROBIOL IMMUNOL RADIOL | 4 | 56% | 2.7% | 5 |
2 | PROTON MED GRP | 1 | 50% | 1.1% | 2 |
3 | MARY CROWLEY MED | 1 | 22% | 2.1% | 4 |
4 | ARAGON INA | 1 | 50% | 0.5% | 1 |
5 | BONE METAB REPAIRTRAUMA SURG | 1 | 50% | 0.5% | 1 |
6 | COMBINED INJURE | 1 | 50% | 0.5% | 1 |
7 | CRI 9508 | 1 | 50% | 0.5% | 1 |
8 | EXPT RADIOT ONCOL | 1 | 50% | 0.5% | 1 |
9 | EXPT THER UET PROGRAM | 1 | 50% | 0.5% | 1 |
10 | LDDRD | 1 | 50% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000257166 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE |
2 | 0.0000205404 | EGR 1//EARLY GROWTH RESPONSE 1//N N BUTYL HALOPERIDOL IODIDE |
3 | 0.0000130151 | TET SYSTEM//PTRIDENT//TET ON SYSTEM |
4 | 0.0000127952 | RECOMBINANT VACCINE GRP//ABSCOPAL EFFECT//IMMUNOGENIC TUMOR CELL DEATH |
5 | 0.0000123028 | GS NITROXIDE//LECITHINIZED SUPEROXIDE DISMUTASE//P INFECT ONCOL |
6 | 0.0000108540 | MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING |
7 | 0.0000089359 | HZ08//IMMUNE POTENTIAL ENZYMES//4 CHLOROPHENOXY ACETIC ACID 4 CPA |
8 | 0.0000085633 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
9 | 0.0000082902 | IEX 1//IMMEDIATE EARLY GENE X 1 IEX 1//IMMEDIATE EARLY RESPONSE GENE X 1 |
10 | 0.0000082247 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS |